SCHEMBL634866

SCHEMBL634866

CC(C)C(NCCc1ccccc1)C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.56
KMT2A Q03164 2/20 0.55
TSHR P16473 2/20 0.55
MEN1 O00255 1/20 0.55
ALDH1A1 P00352 1/20 0.53
HSD17B10 Q99714 1/20 0.52
OPRK1 P41145 1/20 0.51
CYP2D6 P10635 2/20 0.50
CYP2C9 P11712 2/20 0.50
CYP2C19 P33261 2/20 0.50
CA12 O43570 1/20 0.47
CA2 P00918 1/20 0.47
CA9 Q16790 1/20 0.47
ATM Q13315 1/20 0.47
TAAR1 Q96RJ0 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
EPHX1 P07099 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7277829 0.92 CYP2D6 (0.58) SIGMAR1KMT2ACYP2D6CYP2C9CYP2C19
SCHEMBL7277833 0.92 CYP2D6 (0.58) SIGMAR1KMT2ACYP2D6CYP2C9CYP2C19
SCHEMBL27695649 0.85 SIGMAR1 (0.51) SIGMAR1KMT2ATSHRMEN1OPRK1
Hydrochloric Acid SCHEMBL8617614 0.85 SIGMAR1 (0.51) SIGMAR1KMT2ATSHRMEN1ALDH1A1
SCHEMBL29060375 0.84 ALDH1A1 (0.62) SIGMAR1KMT2ATSHRMEN1ALDH1A1
SCHEMBL2398120 0.84 KMT2A (0.66) SIGMAR1KMT2ATSHRMEN1ALDH1A1
SCHEMBL8065362 0.84 ALDH1A1 (0.62) SIGMAR1KMT2ATSHRMEN1ALDH1A1
SCHEMBL2398115 0.84 KMT2A (0.66) SIGMAR1KMT2ATSHRMEN1ALDH1A1
SCHEMBL8349459 0.84 ALDH1A1 (0.62) SIGMAR1KMT2ATSHRMEN1ALDH1A1
Hydrochloric Acid SCHEMBL28019583 0.82 ALDH1A1 (0.60) SIGMAR1KMT2ATSHRMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2419433-A1 HEPATITIS C VIRUS INHIBITORS Bristol-Myers Squibb Company (US) 2012-02-22 EP disclosed
WO-2010120621-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2010-10-21 WO disclosed